[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2022, "totalPay": 84357, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 51, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 690642, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": 346904, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Vice President of Market & Market Access", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 14.88, "open": 14.69, "dayLow": 14.69, "dayHigh": 17.0, "regularMarketPreviousClose": 14.88, "regularMarketOpen": 14.69, "regularMarketDayLow": 14.69, "regularMarketDayHigh": 17.0, "beta": 0.487, "forwardPE": -8.706522, "volume": 72541, "regularMarketVolume": 72541, "averageVolume": 49468, "averageVolume10days": 48870, "averageDailyVolume10Day": 48870, "bid": 15.62, "ask": 25.69, "bidSize": 800, "askSize": 1400, "marketCap": 459357504, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 17.8, "priceToSalesTrailing12Months": 105.648, "fiftyDayAverage": 9.84116, "twoHundredDayAverage": 7.663025, "currency": "USD", "enterpriseValue": 415393600, "floatShares": 11298541, "sharesOutstanding": 28674000, "sharesShort": 188202, "sharesShortPriorMonth": 167704, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0066000004, "heldPercentInsiders": 0.45186, "heldPercentInstitutions": 0.23877001, "shortRatio": 2.83, "shortPercentOfFloat": 0.0107, "bookValue": 3.41, "priceToBook": 4.697947, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -43212000, "trailingEps": -1.84, "forwardEps": -1.84, "enterpriseToRevenue": 95.537, "enterpriseToEbitda": -9.306, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "gmtOffSetMilliseconds": -14400000, "currentPrice": 16.02, "targetHighPrice": 20.08, "targetLowPrice": 17.07, "targetMeanPrice": 18.68, "targetMedianPrice": 18.08, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 57748000, "totalCashPerShare": 2.009, "ebitda": -44638000, "totalDebt": 12704000, "quickRatio": 4.412, "currentRatio": 4.732, "totalRevenue": 4348000, "debtToEquity": 12.96, "revenuePerShare": 0.155, "returnOnAssets": -0.20863001, "returnOnEquity": -0.39581, "revenueGrowth": 0.396, "grossMargins": 0.61914, "operatingMargins": -5.9413395, "financialCurrency": "EUR", "trailingPegRatio": null}]